Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDOramed Pharmaceuticals Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q2 2025 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q3 2025 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q4 2025 | 1 | -$0.08 | -$0.08 | -$0.08 |
Oramed Pharmaceuticals Inc. Earnings Date And Information
Oramed Pharmaceuticals Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-0.48 earnings per share for the quarter, missing analysts' consensus estimates of $-0.0049 by $0.4751. The company had revenue of 0 for the quarter and had revenue of 1.34 M for the year. Oramed Pharmaceuticals Inc. has generated $0 earnings per share over the last year ($0.14 diluted earnings per share) and currently has a price-to-earnings ratio of 21.89. Oramed Pharmaceuticals Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 4th, 2025 based on prior year's report dates.
Oramed Pharmaceuticals Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | -$0.00 | -$0.48 | -0.48 | $250,000 | $0 |
| 08/14/2024 | Q2 2024 | $0.01 | $0.22 | 0.21 | $250,000 | $0 |
| 05/09/2024 | Q1 2024 | $0.02 | $0.04 | 0.02 | N/A | $0 |
| 03/06/2024 | Q4 2023 | -$0.12 | $0.00 | N/A | N/A | $0 |
| 11/09/2023 | Q3 2023 | -$0.09 | -$0.08 | 0.01 | $700,000 | $0 |
| 08/10/2023 | Q2 2023 | -$0.11 | -$0.03 | 0.08 | $700,000 | $674,000 |
| 05/11/2023 | Q1 2023 | -$0.23 | -$0.04 | 0.19 | N/A | $666,000 |
| 03/06/2023 | Q4 2022 | -$0.22 | -$0.22 | 0 | N/A | $681,000 |
| 11/10/2022 | Q3 2022 | -$0.26 | -$0.19 | 0.07 | $696,833 | $682,000 |
| 08/10/2022 | Q2 2022 | -$0.22 | -$0.27 | -0.05 | $700,000 | $674,000 |
| 05/12/2022 | Q1 2022 | N/A | -$0.27 | N/A | N/A | $666,000 |
| 01/11/2022 | Q4 2021 | -$0.20 | -$0.22 | -0.02 | N/A | $674,000 |
| 11/24/2021 | Q3 2021 | -$0.10 | -$0.23 | -0.13 | N/A | $683,000 |
| 07/14/2021 | Q2 2021 | -$0.12 | -$0.17 | -0.05 | N/A | $681,000 |
| 04/13/2021 | Q1 2021 | -$0.19 | -$0.17 | 0.02 | N/A | $665,000 |
| 01/14/2021 | Q4 2020 | -$0.16 | -$0.23 | -0.07 | N/A | $674,000 |
| 11/24/2020 | Q3 2020 | -$0.15 | -$0.13 | 0.02 | N/A | $681,000 |
| 07/07/2020 | Q2 2020 | -$0.15 | -$0.10 | 0.05 | N/A | $681,000 |
| 04/06/2020 | Q1 2020 | -$0.25 | -$0.21 | 0.04 | N/A | $674,000 |
| 01/09/2020 | Q4 2019 | -$0.26 | -$0.15 | 0.11 | N/A | $674,000 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Oramed Pharmaceuticals Inc. Earnings: FAQ's
Oramed Pharmaceuticals Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 4th, 2025 based offlast year's report dates.
The conference call for Oramed Pharmaceuticals Inc.'s latest earnings report can be listened to online.
The conference call transcript for Oramed Pharmaceuticals Inc.'s latest earnings report can be read online.
Oramed Pharmaceuticals Inc. (:ORMP) has a recorded annual revenue of $1.34 M.
Oramed Pharmaceuticals Inc. (:ORMP) has a recorded net income of $5.53 M.Oramed Pharmaceuticals Inc. has generated $0.14 earnings per share over the last four quarters.
Oramed Pharmaceuticals Inc. (:ORMP) has a price-to-earnings ratio of 21.89 and price/earnings-to-growth ratio is -0.1.